awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33438641-2F4C7593-02B4-404C-A697-37500AE66A1F
Q33438641-2F4C7593-02B4-404C-A697-37500AE66A1F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33438641-2F4C7593-02B4-404C-A697-37500AE66A1F
Combination of bevacizumab, irinotecan, and temozolomide for refractory or relapsed neuroblastoma: Results of a phase II study.
P2860
Q33438641-2F4C7593-02B4-404C-A697-37500AE66A1F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33438641-2F4C7593-02B4-404C-A697-37500AE66A1F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
91dc349a061c791da909fb750676498efd167024
P2860
A single-arm pilot phase II study of gefitinib and irinotecan in children with newly diagnosed high-risk neuroblastoma.